{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:08:22Z","timestamp":1761786502634,"version":"build-2065373602"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203146","82172838"],"award-info":[{"award-number":["82203146","82172838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Healthy committee project of Jiangsu province","award":["M2022008"],"award-info":[{"award-number":["M2022008"]}]},{"name":"Clinical Medical Research Center for Obstetrics and Gynecology Disease of Zhenjiang","award":["SS2022003"],"award-info":[{"award-number":["SS2022003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02248-8","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:49:10Z","timestamp":1761745750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel frameshift variation of PKD1 in familial autosomal dominant polycystic kidney diseases: expanding the clinical phenotype and genetic spectrum of PKD1 disorders"],"prefix":"10.1186","volume":"18","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"2248_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet (London England). 2019;393:919\u201335.","journal-title":"Lancet (London England)"},{"key":"2248_CR2","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1001\/jama.2022.22847","volume":"328","author":"AR Chang","year":"2022","unstructured":"Chang AR, Moore BS, Luo JZ, Sartori G, Fang B, Jacobs S, Abdalla Y, Taher M, Carey DJ, Triffo WJ, Singh G, Mirshahi T. Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease. JAMA. 2022;328:2412\u201321.","journal-title":"JAMA"},{"key":"2248_CR3","first-page":"155","volume":"13","author":"MC Hogan","year":"2015","unstructured":"Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RW. Liver involvement in early autosomal-dominant polycystic kidney disease, clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association. 2015;13:155\u2013e164156.","journal-title":"J Am Gastroenterological Association"},{"key":"2248_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2215\/CJN.14691218","volume":"14","author":"IM Sanchis","year":"2019","unstructured":"Sanchis IM, Shukoor S, Irazabal MV, Madsen CD, Chebib FT, Hogan MC, El-Zoghby Z, Harris PC, Huston J, Brown RD, Torres VE. Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrology: CJASN. 2019;14:1151\u201360.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"2248_CR5","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","volume":"385","author":"AC Ong","year":"2015","unstructured":"Ong AC, Devuyst O, Knebelmann B, Walz G. Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet (London England). 2015;385:1993\u20132002.","journal-title":"Lancet (London England)"},{"key":"2248_CR6","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s00467-022-05870-1","volume":"38","author":"N Demoulin","year":"2023","unstructured":"Demoulin N., Van Regemorter E., Dahan K., Hougardy C., Morelle J., Gillion V., Ranguelov N., Godefroid N. Severe parental phenotype associates with hypertension in children with ADPKD. Pediatr Nephrol. 2023;38:2733\u201340.","journal-title":"Pediatr Nephrol"},{"key":"2248_CR7","doi-asserted-by":"crossref","unstructured":"Lanktree MB, Guiard E, Akbari P, Pourafkari M, Iliuta IA, Ahmed S, Haghighi A, He N, Song X, Paterson AD, Khalili K, Pei YPC. Patients with Protein-Truncating PKD1 mutations and mild ADPKD, clinical journal of the American society of nephrology. Volume 16. CJASN; 2021. pp. 374\u201383.","DOI":"10.2215\/CJN.11100720"},{"key":"2248_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le","year":"2018","unstructured":"Cornec-Le E, Gall VE, Torres PC, Harris. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrology: JASN. 2018;29:13\u201323.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"2248_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","volume":"109","author":"SR Senum","year":"2022","unstructured":"Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audr\u00e9zet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le E, Gall MC, Hogan VE, Torres JA, Sayer PC, Harris. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet. 2022;109:136\u201356.","journal-title":"Am J Hum Genet"},{"key":"2248_CR10","doi-asserted-by":"publisher","first-page":"e63841","DOI":"10.1002\/ajmg.a.63841","volume":"194","author":"D Clark","year":"2024","unstructured":"Clark D, Burns R, Bloom MS, Lim KPH, Li L, Vincent LM, Xie J, Xue Y, Punj S. Heterozygous loss of function variants in IFT140 are associated with polycystic kidney disease. Am J Med Genet: A. 2024;194:e63841.","journal-title":"Am J Med Genet: A"},{"key":"2248_CR11","doi-asserted-by":"publisher","first-page":"105943","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105943","volume":"30","author":"K Shigemori","year":"2021","unstructured":"Shigemori K, Higashihara E, Itoh M, Yoshida H, Yamamoto K, Nutahara K, Shiokawa Y, Kaname S, Tambo M, Yamaguchi T, Taguchi S, Yoshioka T, Yokoyama K, Fukuhara H. PKD1-Associated arachnoid cysts in autosomal dominant polycystic kidney disease. J Stroke Cerebrovasc Diseases: Official J Natl Stroke Association. 2021;30:105943.","journal-title":"J Stroke Cerebrovasc Diseases: Official J Natl Stroke Association"},{"key":"2248_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000530657","volume":"148","author":"S Orisio","year":"2024","unstructured":"Orisio S, Noris M, Rigoldi M, Bresin E, Perico N, Trillini M, Donadelli R, Perna A, Benigni A, Remuzzi G. Mutation analysis of PKD1 and PKD2 genes in a large Italian cohort reveals novel pathogenic variants including a novel complex rearrangement. Nephron. 2024;148:273\u201391.","journal-title":"Nephron"},{"key":"2248_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nefro.2022.11.003","volume":"44","author":"I Gal\u00e1n Carrillo","year":"2024","unstructured":"Gal\u00e1n Carrillo I, Galbis Mart\u00ednez L, Mart\u00ednez V, Roca Mero\u00f1o S, Ramos F, Gonz\u00e1lez Rodr\u00edguez JD, Pi\u00f1ero Fern\u00e1ndez J. Guill\u00e9n Navarro, multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. Nefrologia. 2024;44:69\u201376.","journal-title":"Nefrologia"},{"key":"2248_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12920-023-01725-2","volume":"16","author":"P Xu","year":"2023","unstructured":"Xu P, Wang L, Li J, Huang S, Gao M, Kang R, Li J, Xie H, Liu X, Yan J, Gao X, Gao Y. OGM and WES identifies translocation breakpoints in PKD1 gene in an polycystic kidney patient and healthy baby delivered using PGT. BMC Med Genom. 2023;16:285.","journal-title":"BMC Med Genom"},{"key":"2248_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/08860229909066971","volume":"21","author":"D Papadopoulou","year":"1999","unstructured":"Papadopoulou D, Tsakiris D, Papadimitriou M. The use of ultrasonography and linkage studies for early diagnosis of autosomal dominant polycystic kidney disease (ADPKD). Ren Fail. 1999;21:67\u201384.","journal-title":"Ren Fail"},{"key":"2248_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000491022","volume":"48","author":"R Magistroni","year":"2018","unstructured":"Magistroni R, Corsi C, Mart\u00ed T, Torra R. A review of the imaging techniques for measuring kidney and cyst volume in Establishing autosomal dominant polycystic kidney disease progression. Am J Nephrol. 2018;48:67\u201378.","journal-title":"Am J Nephrol"},{"key":"2248_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1053\/j.ajkd.2018.01.048","volume":"72","author":"EL Murphy","year":"2018","unstructured":"Murphy EL, Droher ML, DiMaio MS, Dahl NK. Preimplantation genetic diagnosis counseling in autosomal dominant polycystic kidney disease. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2018;72:866\u201372.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"key":"2248_CR18","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular Pathology, genetics in medicine: official. J Am Coll Med Genet. 2015;17:405\u201324.","journal-title":"J Am Coll Med Genet"},{"key":"2248_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","volume":"49","author":"M Losekoot","year":"2012","unstructured":"Losekoot M, Ruivenkamp CA, Tholens AP, Grimbergen JE, Vijfhuizen L, Vermeer S, Dijkman HB, Cornelissen EA, Bongers EM, Peters DJ. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy. J Med Genet. 2012;49:37\u201340.","journal-title":"J Med Genet"},{"key":"2248_CR20","doi-asserted-by":"publisher","first-page":"937580","DOI":"10.3389\/fcell.2022.937580","volume":"10","author":"S Shang","year":"2022","unstructured":"Shang S, Wang C, Chen L, Shen W, Xie Y, Li W, Li Q. Novel method for the genomic analysis of PKD1 mutation in autosomal dominant polycystic kidney disease. Front Cell Dev Biology. 2022;10:937580.","journal-title":"Front Cell Dev Biology"},{"key":"2248_CR21","doi-asserted-by":"crossref","unstructured":"Mantovani V, Bin S, Graziano C, Capelli I, Minardi R, Aiello V, Ambrosini E, Cristalli CP, Mattiaccio A, Pariali M, De Fanti S, Faletra F, Grosso E, Cantone R, Mancini E, Mencarelli F, Pasini A, Wischmeijer A, Sciascia N, Seri M. G. La Manna, gene panel analysis in a large cohort of patients with autosomal dominant polycystic kidney disease allows the identification of 80 potentially causative novel variants and the characterization of a complex genetic architecture in a subset of Families, frontiers in genetics, 11 (2020) 464.","DOI":"10.3389\/fgene.2020.00464"},{"key":"2248_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3109\/0886022X.2014.890010","volume":"36","author":"C Yu","year":"2014","unstructured":"Yu C, Li J, Yuan Z, Liu S, Zou L. Two novel mutations affecting the same splice site of PKD1 correlate with different phenotypes in ADPKD. Ren Fail. 2014;36:687\u201393.","journal-title":"Ren Fail"},{"key":"2248_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12881-018-0693-7","volume":"19","author":"WB He","year":"2018","unstructured":"He WB, Xiao WJ, Tan YQ, Zhao XM, Li W, Zhang QJ, Zhong CG, Li XR, Hu L, Lu GX, Lin G, Du J. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction. BMC Med Genet. 2018;19:186.","journal-title":"BMC Med Genet"},{"key":"2248_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41436-020-01026-4","volume":"23","author":"M Durkie","year":"2021","unstructured":"Durkie M, Chong J, Valluru MK, Harris PC, Ong ACM. Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease. Genet Medicine: Official J Am Coll Med Genet. 2021;23:689\u201397.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"key":"2248_CR25","doi-asserted-by":"publisher","first-page":"e27853","DOI":"10.1097\/MD.0000000000027853","volume":"103","author":"T Wei","year":"2024","unstructured":"Wei T, Zhang B, Tang W, Li X, Shuai Z, Tang T, Zhang Y, Deng L, Liu Q. A de Novo PKD1 mutation in a Chinese family with autosomal dominant polycystic kidney disease. Medicine. 2024;103:e27853.","journal-title":"Medicine"},{"key":"2248_CR26","first-page":"507","volume":"17","author":"J Meng","year":"2019","unstructured":"Meng J, Xu Y, Shen X, Liang C. A novel frameshift PKD1 mutation in a Chinese patient with autosomal dominant polycystic kidney disease and azoospermia: A case report. Experimental Therapeutic Med. 2019;17:507\u201311.","journal-title":"Experimental Therapeutic Med"},{"key":"2248_CR27","doi-asserted-by":"crossref","unstructured":"Rai V, Singh M, Holthoff JH. New Mutation Associated with Polycystic Kidney Disease Type I: A Case Report . Genes. 2024;15(10):1262.","DOI":"10.3390\/genes15101262"},{"key":"2248_CR28","doi-asserted-by":"crossref","unstructured":"Aklilu AM, Gulati A, Kolber KJ, Yang H, Harris PC, Dahl NK. The VUS challenge in cystic kidney disease: A Case-Based Review. Kidney360. 2024;5(1):152\u2013159.","DOI":"10.34067\/KID.0000000000000298"},{"key":"2248_CR29","doi-asserted-by":"publisher","first-page":"1268307","DOI":"10.3389\/fmed.2023.1268307","volume":"10","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Aierken A, Yalikun D, Zhang J, Wang X, Ren Y, Tian X, Jiang H. Case report: Genotype-phenotype characteristics of nine novel PKD1 mutations in eight Chinese patients with autosomal dominant polycystic kidney disease. Front Med. 2023;10:1268307.","journal-title":"Front Med"},{"key":"2248_CR30","doi-asserted-by":"crossref","unstructured":"Righini M, Mancini R, Busutti M, Buscaroli A. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. Int J Mol Sci. 2024;25(5):2554.","DOI":"10.3390\/ijms25052554"},{"key":"2248_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MPA.0000000000001306","volume":"48","author":"B.A McNicholas","year":"2019","unstructured":"McNicholas B.A., Kotaro Y, Martin W, Sharma A, Kamath P.S., Edwards M.E., Kremers W.K., Chari S.T., Torres V.E., Harris P.C., Takahashi N., Hogan M.C. Pancreatic cysts and intraductal papillary mucinous neoplasm in autosomal dominant polycystic kidney disease. Pancreas. 2019;48:698\u2013705.","journal-title":"Pancreas"},{"key":"2248_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3174\/ajnr.A8407","volume":"46","author":"U Sattar","year":"2025","unstructured":"Sattar U, Yin X, Luo X, Zhu C, Hu Z, Blumenfeld JD, Rennert H, Wu A, RoyChoudhury A, Salama G, Prince MR. Prevalence of spinal meningeal diverticula in autosomal dominant polycystic kidney Disease, AJNR. Am J Neuroradiol. 2025;46:200\u20136.","journal-title":"Am J Neuroradiol"},{"key":"2248_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fneur.2018.00383","volume":"9","author":"C Thomas","year":"2018","unstructured":"Thomas C, Z\u00fchlsdorf A, H\u00f6rtnagel K, Mulahasanovic L, Grauer OM, K\u00fcmpers P, Wiendl H, Meuth SG. A novel PKD1 mutation associated with autosomal dominant kidney disease and cerebral cavernous malformation. Front Neurol. 2018;9:383.","journal-title":"Front Neurol"},{"key":"2248_CR34","doi-asserted-by":"crossref","unstructured":"Barten TRM, B\u00f6kkerink RMP, Venderink W, Gevers TJG, Ten Broek RPG, Drenth JPH. Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly, liver international. Volume 42. official journal of the International Association for the Study of the Liver; 2022. pp. 871\u20138.","DOI":"10.1111\/liv.15177"},{"key":"2248_CR35","doi-asserted-by":"crossref","unstructured":"Kaori S, Eiji H, Masayuki I, Hiroki Y, Kouji Y, Kikuo N, Yoshiaki S, Shinya K, Mitsuhiro T, Tsuyoshi Y, Satoru T, Tatsuya Y, Kenichi Y, Hiroshi F. PKD1-Associated arachnoid cysts in autosomal dominant polycystic kidney disease. J Stroke Cerebrovasc Diseases: Official J Natl Stroke Association. 2021;30(9):105943.","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105943"},{"key":"2248_CR36","doi-asserted-by":"crossref","unstructured":"Fabienne K, Uzeyir A, Spyros K, J\u00f6rg B, Rudolf W, Andreas PS, Diane LP. Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance. Clin Kidney J. 2012;5(5):405\u2013411.","DOI":"10.1093\/ckj\/sfs111"},{"key":"2248_CR37","first-page":"2771","volume":"39","author":"AK Ahmed","year":"2023","unstructured":"Ahmed AK, Cohen AR. Intracranial arachnoid cysts, child\u2019s nervous system: ChNS. : Official J Int Soc Pediatr Neurosurg. 2023;39:2771\u20138.","journal-title":": Official J Int Soc Pediatr Neurosurg"},{"key":"2248_CR38","first-page":"479","volume":"97","author":"M Merta","year":"1996","unstructured":"Merta M, Rysav\u00e1 R. [Brain disorders in autosomal dominant polycystic kidney disease]. Sb Lek. 1996;97:479\u201385.","journal-title":"Sb Lek"},{"key":"2248_CR39","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1542\/peds.110.1.e13","volume":"110","author":"FK Alehan","year":"2002","unstructured":"Alehan FK, G\u00fcrakan B, A\u011fildere M. Familial arachnoid cysts in association with autosomal dominant polycystic kidney disease. Pediatrics. 2002;110:e13.","journal-title":"Pediatrics"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02248-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:03:28Z","timestamp":1761786208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02248-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02248-8","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance to the Declaration of Helsinki and was approved by Ethics Committee of Fourth affiliated hospital of Jiangsu University. All participants agreed to participate in the study and provided signed informed consent. Written informed consent to participate has been obtained from all the participants and the parents\/legal guardians of minors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}